Загрузка...
Etanercept in the treatment of rheumatoid arthritis
Etanercept (ETN) is the first anti-tumor necrosis factor (TNF) agent to be approved for the treatment of rheumatoid arthritis (RA). Over the last 8 years, several clinical trials have shown its efficacy and safety in established and early RA, as well as a monotherapy or in combination with methotrex...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2007
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936291/ https://ncbi.nlm.nih.gov/pubmed/18360618 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|